Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 3Phase 2/3 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Prostatic Neoplasms 1Colorectal Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 648Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 273

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Niclosamide × Clear all
NCT02807805 2024-12-18

Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

University of California, Davis

Phase 2 Active not recruiting
37 enrolled
Genitourinary

Prostatic Neoplasms

NCT04296851 2020-03-05

Niclosamide for Familial Adenomatous Polyposis

Yonsei University

Phase 2 Unknown
72 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT02519582 2018-09-12

Nikolo

Charite University, Berlin, Germany

Phase 2 Unknown
37 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡